Your browser doesn't support javascript.
loading
Discovery of XEN445: a potent and selective endothelial lipase inhibitor raises plasma HDL-cholesterol concentration in mice.
Sun, Shaoyi; Dean, Richard; Jia, Qi; Zenova, Alla; Zhong, Jing; Grayson, Celene; Xie, Clark; Lindgren, Andrea; Samra, Pritpaul; Sojo, Luis; van Heek, Margaret; Lin, Linus; Percival, David; Fu, Jian-Min; Winther, Michael D; Zhang, Zaihui.
Affiliation
  • Sun S; Xenon Pharmaceuticals Inc, 200-3650 Gilmore Way, Burnaby, BC V5G 4W8, Canada. Electronic address: ssun@xenon-pharma.com.
Bioorg Med Chem ; 21(24): 7724-34, 2013 Dec 15.
Article in En | MEDLINE | ID: mdl-24211162

Full text: 1 Database: MEDLINE Main subject: Pyrrolidines / Benzoates / Enzyme Inhibitors / Drug Discovery / Lipase / Cholesterol, HDL Limits: Animals Language: En Year: 2013 Type: Article

Full text: 1 Database: MEDLINE Main subject: Pyrrolidines / Benzoates / Enzyme Inhibitors / Drug Discovery / Lipase / Cholesterol, HDL Limits: Animals Language: En Year: 2013 Type: Article